Avery Shuei-He Yang, MClinPharm

School Of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Taiwan (Republic of China)

Disclosure information not submitted.

Presentation(s):

• SW-2B - The Clone-Censor-Weight Approach: From Basic Principles to Its Transformation in Diverse Exposure and Outcome Scenarios

  Sunday, August 24, 2025
  5:15 PM - 6:45 PM ET

• 3B-01 - Risk of secondary thromboembolism event following intravitreal injections of anti-VEGF agents: A target-trial emulation study

  Monday, August 25, 2025
  8:15 AM - 8:30 AM ET

• 5B-03 - Comparing Clone-Censoring Weighting and Sequential Trial Emulation in Estimating the Effect of Statins on Major Adverse Cardiovascular Events in Patients with Diabetes Mellitus

  Tuesday, August 26, 2025
  9:00 AM - 9:15 AM ET

• 6F-02 - Evaluation of Different Washout Periods for Identifying New Users

  Tuesday, August 26, 2025
  1:45 PM - 2:00 PM ET

• 6G-04 - Risk of Osteoporosis, Osteoporotic Fractures, and Falls in Patients With Rheumatoid Arthritis Receiving JAK Inhibitors: A Target Trial Emulation Study

  Tuesday, August 26, 2025
  2:15 PM - 2:30 PM ET